Accelrys’ solutions are used by more than 1,300 customers in the pharmaceutical, biotechnology, energy, chemicals, aerospace, consumer packaged goods and industrial products industries. Accelrys employs more than 200 full-time doctoral scientists. The company’s Accelrys Enterprise Platform provides a broad, flexible scientific solution optimized to integrate the diversity of science, experimental processes and information requirements across the research, development, process scale-up and early manufacturing phases of product development. By incorporating capabilities in applications for modeling and simulation, enterprise lab management, workflow and automation and data management and informatics, Accelrys enables its customers to organize, analyze and share data to enhance innovation, improve productivity and compliance, reduce costs and speed time from lab to market.  

 

---

 

Accelrys inks software-licensing agreement with Gulf Coast Consortia  

 

SAN DIEGO—Accelrys Inc. announced June 4 that it signed a five-year licensing agreement with the Gulf Coast Consortia (GCC) for Quantitative Biomedical Sciences to provide investigators in the GCC Chemical Genomics (GCC-CG) program with access to scientific software, services and training. The Accelrys software will be used to support multidisciplinary collaborative research and training programs for the treatment and prevention of diseases, including rare and undertreated cancers.  

 

Offered through the Accelrys Academic Program, the licensed software includes the scientifically enabled, enterprise-scalable Accelrys Enterprise Platform supporting multicenter, collaborative information sharing and scientific innovation across partnering research organizations. The system also includes Accelrys Pipeline Pilot (the platform's scientific authoring solution), the Cloud-based Accelrys HEOS drug discovery information management workspace, the Accelrys Discovery Studio modeling and simulation application and Accelrys Biological Registration software.

 

“Large, interinstitutional cooperatives focused on collaborative research and interdisciplinary training represent a new operating paradigm in academia today,” said Accelrys Senior Vice President and Chief Technology Officer Dr. Matt Hahn. “Accelrys’ unifying Enterprise Platform defines a new standard in integrated research informatics for multicenter collaborations. The software package tailored for GCC and delivered through Accelrys’ Academic Program provides immediate access to shared state-of-the-art solutions, enabling university partners to hit the ground running with project delivery.”  

 

“Plug-and-play deployment and ease of use in a seamless integrated network requiring minimal support by internal resources were the driving factors that led our group to adopt Accelrys technology,” said GCC-CG director and co-founder Dr. Peter Davies, professor and director of the Center for Translational Cancer Research’s Institute of Biosciences and Technology at Texas A&M Health Center. “With upwards of 30 projects a year, we need to work together efficiently and generate results quickly with minimal time and resources spent on internal software development. The ability to create Pipeline Pilot Web applications that can be freely shared with other academic researchers inside or outside the consortia provides a significant collaboration and innovation benefit.”

 

“For several years, our assay development efforts and screening program have always had a sizable high-throughput microscopy-based emphasis using Pipeline Pilot-based imaging tools. We are extremely pleased to now be able to integrate high-content analysis/screening data and reporting across the entire program using HEOS,” said Dr. Michael Mancini, associate professor in the department of Molecular and Cellular Biology at Baylor College of Medicine, and co-founder/co-director of the GCC-CG.  

 

The mission of the GCC is to build and support interdisciplinary collaborative research teams and training programs in the biological sciences and apply the resulting expertise and knowledge to the treatment and prevention of diseases. The GCC brings together preeminent principal investigators from several world-renowned research institutions including founding members Baylor College of Medicine, Rice University, the University of Houston, the University of Texas Health Science Center at Houston (UTHealth), the University of Texas MD Anderson Cancer Center and the University of Texas Medical Branch at Galveston.  

 

In addition to the GCC founding institutions, the GCC-CG includes the Methodist Hospital Research Institute, the University of Texas at Austin’s Texas Institute for Drug and Diagnostic Development, Texas A&M Health Science Center’s Institute for Biosciences and Technology, Texas Southern University and the University of Texas-El Paso.